Congress orders first major audit of VA mental health care versus private providers

What it does

This bill requires the Department of Veterans Affairs to commission an independent study comparing the quality of mental health and addiction treatment provided by VA facilities versus private providers. The study will examine treatment outcomes, use of evidence-based practices, care coordination, patient satisfaction, and wait times across different treatment modalities, with results published within 18 months and shared with Congress and the public.

Why we flagged it

The bill's core function is to mandate a comparative quality study of VA versus private mental health and addiction services. It is a transparency and accountability measure, not a funding mechanism, regulatory change, or commemorative act.

What the text implies

• Study results may reveal significant performance gaps in VA mental health services, potentially triggering pressure for increased VA funding or expanded private-provider partnerships.
• Comparison of wait times and access metrics could expose systemic VA delays, creating political momentum for policy changes that shift veteran care toward private networks.
• Evidence-based practice assessment may highlight gaps in VA provider training or certification, leading to workforce development mandates or outsourcing of specialized services.
• Public reporting of patient satisfaction and outcomes data will create a permanent benchmark against which future VA performance is measured, raising accountability expectations.

Who it affects

Veterans and their families gain transparency about the relative quality of VA versus private mental health and addiction services, enabling informed decisions about care. The public gains accountability data on how taxpayer-funded VA services perform, and the study may identify gaps that drive policy improvements.

Who stands to gain

• private mental health and addiction treatment providers
• telehealth platforms serving veterans
• pharmaceutical companies (if study drives treatment protocol changes)
• independent research organizations conducting the study

Named in the bill

Department of Veterans Affairs, House Committee on Veterans' Affairs, Senate Committee on Veterans' Affairs, American Society of Addiction Medicine, Columbia-Suicide Severity Rating Scale, BMY (Bristol Myers Squibb), GH (Guardant Health), PFE (Pfizer), DVA (DaVita HealthCare Partners), JNJ (Johnson & Johnson)

Where it stands

12 cosponsors: 6 Democrats, 6 Republicans.

• Mar 27, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 27, 2025 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
• Jan 13, 2026 — Hearing held · Congress.gov: “Subcommittee Hearings Held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

6 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,336,437 in lobbying spend. A filing names 74 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 82% of bills with at least one filing.

Pat Fallon, the sponsor, reported $359,260 in PAC receipts in the 2026 cycle.

• American Psychiatric Association — $391,974 on 1 filing
• American Psychological Association Services Inc.(fka American Psychological Assn — $340,000 on 1 filing
• Disabled American Veterans — $310,451 on 2 filings
• Association of the United States Army, (inc.) — $224,012 on 2 filings
• United Services Automobile Association (usaa) — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.